. Leonard was diagnosed at a much younger age of 54. They say at first, many of his doctors even brushed off his concerns."Argue with the doctors that this isn't just stress, this is something really different," Garrity said.. The move marks the firsT time that a drug meant to slow down the progression of the disease has been granted full regulatory approval.
"The benefit is that it helps the slow cognitive decline by about 27% after about 18 months of treatment," said Meredith Wicklund, a Mayo Clinic neurologist. "Unfortunately, it doesn’t improve cognition, but it does help solve both cognitive and functional decline, allowing individuals to stay in a good functioning state for as long as possible."The United States Food and Drug Administration has approved a game-changing drug for the treatment of Alzheimers.
"You go to get infusions twice a week it was going to be, I was figuring just south of five grand a month, but since it’s been approved and CMS is going to cover it, it's like we are ready to go," Chayrez said. But that time is ticking. The drug is prescribed for those in the early stages of the disease. Leonard will have his first infusion later this month.
"Every day 2,000 people move from early stage to middle stage; their door is shut. So that’s 2,000 people a day, so we need to jump on this as quickly as we can so that we can keep him in the early stage as long as possible," Garrity said.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: CNBC - 🏆 12. / 72 Read more »
Source: KPRC2 - 🏆 80. / 68 Read more »
Source: abc15 - 🏆 263. / 63 Read more »